Literature DB >> 3263234

Differential immunosuppressive action of carbimazole and propylthiouracil.

R Wilson1, J H McKillop, C Pearson, A K Burnett, J A Thomson.   

Abstract

Carbimazole and Propylthiouracil (PTU) are widely used in the treatment of Graves' disease, although controversy still exists as to whether or not they have any direct effect on the immune system. While many previous studies have investigated the possible effects of one or other of these drugs on the immune system only a few have directly compared the effects of equivalent doses of each drug. This study aimed to examine the effects of both drugs, during the initial 8 weeks of treatment, on various biochemical and immunological parameters. The results obtained showed that while thyroid hormone levels fell at similar rates in both treatment groups, TRAb levels and T cell subset abnormalities returned towards normal more rapidly in patients receiving Carbimazole compared to PTU. These results indicate that the effects of Carbimazole on TRAb levels and T cell subset abnormalities are not due solely to its action in controlling the biochemical features of Graves' disease and provide indirect evidence of an action on the immune system in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263234      PMCID: PMC1541608     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

Review 1.  Evidence that antithyroid drugs induce remissions in Graves' disease by modulating thyroid cellular activity.

Authors:  R Volpé; A Karlsson; R Jansson; P A Dahlberg
Journal:  Clin Endocrinol (Oxf)       Date:  1986-10       Impact factor: 3.478

2.  Prediction of relapse in hyperthyroid Graves' disease.

Authors:  A M McGregor; B R Smith; R Hall; M M Petersen; M Miller; P J Dewar
Journal:  Lancet       Date:  1980-05-24       Impact factor: 79.321

3.  Are antithyroid drugs immunosuppressive?

Authors:  P Kendall-Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

4.  The effect of carbimazole on thyroid autoantibody synthesis by thyroid lymphocytes.

Authors:  S M McLachlan; C A Pegg; M C Atherton; S Middleton; E T Young; F Clark; B R Smith
Journal:  J Clin Endocrinol Metab       Date:  1985-06       Impact factor: 5.958

5.  Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.

Authors:  R H Knopp; C E Walden; P W Wahl; J J Hoover; G R Warnick; J J Albers; J T Ogilvie; W R Hazzard
Journal:  J Clin Endocrinol Metab       Date:  1981-12       Impact factor: 5.958

6.  An improved radioreceptor assay for TSH receptor antibodies.

Authors:  G Shewring; B R Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1982-10       Impact factor: 3.478

7.  Effects of antithyroid drugs on lymphocyte function in vitro.

Authors:  B Hallengren; A Forsgren; A Melander
Journal:  J Clin Endocrinol Metab       Date:  1980-08       Impact factor: 5.958

8.  Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.

Authors:  J Charreire; G Karsenty; P Bouchard; G Schaison
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.

Authors:  K W Wenzel; J R Lente
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

10.  Thyroxine, methimazole, and thyroid microsomal autoantibody titres in hypothyroid Hashimoto's thyroiditis.

Authors:  R Jansson; A Karlsson; P A Dahlberg
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05
View more
  2 in total

Review 1.  Relapse prediction in Graves´ disease: Towards mathematical modeling of clinical, immune and genetic markers.

Authors:  Christoph Langenstein; Diana Schork; Klaus Badenhoop; Eva Herrmann
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

2.  The effects of royal jelly on autoimmunity in Graves' disease.

Authors:  Cihangir Erem; Orhan Deger; Ercüment Ovali; Yasam Barlak
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.